- Bevorzugter Name
- Elaterinide
- IUPAC
- [(E)-6-hydroxy-6-[16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate
Namen und Synonyme
Elaterinide(3E)-6-hydroxy-6-(13-hydroxy-1,6,6,11,15-pentamethyl-5,17-dioxo-4-((3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)tetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,7-dien-14-yl)-2-methyl-5-oxohept-3-en-2-yl acetate(3E)-6-hydroxy-6-(13-hydroxy-1,6,6,11,15-pentamethyl-5,17-dioxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,7-dien-14-yl)-2-methyl-5-oxohept-3-en-2-yl acetateRefChem:9208782-O-beta-D-glycopyranosyl-cucurbitacin ECuegCHEBI:186118NSC177857NSC-177857[(E)-6-hydroxy-6-[16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate[(E)-5-hydroxy-5-[16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-1,1-dimethyl-4-oxo-hex-2-enyl] acetate5-(2-(Hexopyranosyloxy)-16-hydroxy-4,4,9,14-tetramethyl-3,11-dioxoestra-1,5-dien-17-yl)-5-hydroxy-1,1-dimethyl-4-oxo-2-hexenyl acetate
Datenbank-Bezeichner